208 related articles for article (PubMed ID: 26569424)
21. The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma.
Pelizzo MR; Dobrinja C; Casal Ide E; Zane M; Lora O; Toniato A; Mian C; Barollo S; Izuzquiza M; Guerrini J; De Manzini N; Merante Boschin I; Rubello D
Biomed Pharmacother; 2014 May; 68(4):413-7. PubMed ID: 24721322
[TBL] [Abstract][Full Text] [Related]
22. Absence of BRAF V600E in non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma.
Howitt BE; Paulson VA; Barletta JA
Histopathology; 2015 Oct; 67(4):579-82. PubMed ID: 25736029
[No Abstract] [Full Text] [Related]
23. Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer.
Park JY; Yi JW; Park CH; Lim Y; Lee KH; Lee KE; Kim JH
Cancer Genomics Proteomics; 2016; 13(2):171-81. PubMed ID: 26912807
[TBL] [Abstract][Full Text] [Related]
24. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
[TBL] [Abstract][Full Text] [Related]
25. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
26. Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas.
Kim BH; Kim IJ; Lee BJ; Lee JC; Kim IS; Kim SJ; Kim WJ; Jeon YK; Kim SS; Kim YK
Yonsei Med J; 2015 May; 56(3):634-40. PubMed ID: 25837167
[TBL] [Abstract][Full Text] [Related]
27. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation.
Moses W; Weng J; Khanafshar E; Duh QY; Clark OH; Kebebew E
J Surg Res; 2010 May; 160(2):179-83. PubMed ID: 19765726
[TBL] [Abstract][Full Text] [Related]
28. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
Smith RA; Salajegheh A; Weinstein S; Nassiri M; Lam AK
Hum Pathol; 2011 Apr; 42(4):500-6. PubMed ID: 21167555
[TBL] [Abstract][Full Text] [Related]
29. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
[TBL] [Abstract][Full Text] [Related]
30. Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.
Piscazzi A; Costantino E; Maddalena F; Natalicchio MI; Gerardi AM; Antonetti R; Cignarelli M; Landriscina M
J Clin Endocrinol Metab; 2012 Jun; 97(6):E898-906. PubMed ID: 22442268
[TBL] [Abstract][Full Text] [Related]
31. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
[TBL] [Abstract][Full Text] [Related]
32. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
[TBL] [Abstract][Full Text] [Related]
33. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
34. Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma.
Gandolfi G; Sancisi V; Piana S; Ciarrocchi A
Int J Cancer; 2015 Sep; 137(5):1001-11. PubMed ID: 24828987
[TBL] [Abstract][Full Text] [Related]
35. The correlation of sodium iodide symporter and BRAF(V600E) mutation in classical variant papillary thyroid carcinoma.
Yazgan A; Yıldırım N; Gözalan A; Gümüştaş S; Kılıçarslan A; Balci S; Aydın C; Ersoy R; Cakir B; Güler G
Ann Diagn Pathol; 2016 Jun; 22():58-62. PubMed ID: 27180062
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS
Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810
[TBL] [Abstract][Full Text] [Related]
37. Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma.
Shi CL; Sun Y; Ding C; Lv YC; Qin HD
Genet Mol Res; 2015 Jul; 14(3):7377-85. PubMed ID: 26214416
[TBL] [Abstract][Full Text] [Related]
38. BRAF(V600E) mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma.
Jing FJ; Liang J; Liang ZY; Meng C; Long W; Li XY; Lin YS
Chin Med J (Engl); 2013 Aug; 126(16):3013-8. PubMed ID: 23981603
[TBL] [Abstract][Full Text] [Related]
39. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer.
Abd Elmageed ZY; Sholl AB; Tsumagari K; Al-Qurayshi Z; Basolo F; Moroz K; Boulares AH; Friedlander P; Miccoli P; Kandil E
Surgery; 2017 Apr; 161(4):1122-1128. PubMed ID: 27919446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
